30: MCC950 is a potent and specific inhibitor of the NLRP3 inflammasome and a novel potential therapeutic for NLRP3 driven diseases
References (0)
Cited by (0)
- 1
Rebecca C. Coll and Avril A.B. Robertson will both present this work.
Copyright © 2014 Published by Elsevier Ltd.